The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in Radiation Therapy Oncology Group prospective trials 0116 and 0128

International Journal of Gynecological Cancer

Volumn 22, Issue 1, 2012, Pages 123-131

  Viswanathan, Akila N ^a   Moughan, Jennifer ^b   Small, William ^c   Levenback, Charles ^d   Iyer, Revathy ^d   Hymes, Sharon ^d   Dicker, Adam P ^e   Miller, Brigitte ^f   Erickson, Beth ^g   Gaffney, David K ^h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f Batte Cancer Center   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY OF UTAH   (United States)

Author keywords

Brachytherapy quality; Cervical cancer

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEALTH CARE QUALITY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIOLOGICAL PARAMETERS; TREATMENT FAILURE; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

EID: 84858163520     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823ae3c9     Document Type: Article

References (27)

1. Lanciano RM,Won M, Coia L, et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 Patterns of Care studies. Int J Radiat Oncol Biol Phys. 1991;20:667-676.
2. Montana GS, Fowler WC, Varia MA, et al. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer. 1986;57:148-154. (Pubitemid 16212251)
3. Perez CA, Breaux S, Madoc-Jones H, et al. Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence. Cancer. 1983;51:1393-1402. (Pubitemid 13162133)
4. Viswanathan AN, Cormack R, Rawal B, et al. Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer. Int J Gynecol Cancer. 2009;19:1402-1406.
5. Corn BW, Hanlon AL, Pajak TF, et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol. 1994;53:294-300. (Pubitemid 24187856)
6. Potish RA. The effect of applicator geometry on dose specification in cervical cancer. Int J Radiat Oncol Biol Phys. 1990;18:1513-1520. (Pubitemid 20234167)
7. Erickson B, Eifel P, Moughan J, et al. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a Patterns of Care study. Int J Radiat Oncol Biol Phys. 2005;63:1083-1092. (Pubitemid 41505287)
8. Eifel PJ, Moughan J, Erickson B, et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a Patterns of Care study. Int J Rad Oncol Biol Phys. 2004;60:1144-1153. (Pubitemid 39440800)
9. Eifel PJ, Moughan J, Owen J, et al. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of Care study. Int J Radiat Oncol Biol Phys. 1999;43:351-358. (Pubitemid 29091476)
10. Nag S, Chao C, Erickson B, et al. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;52:33-48. (Pubitemid 34041564)
11. Katz A, Eifel PJ. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:1417-1425.
12. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-880. (Pubitemid 41103599)
13. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153. (Pubitemid 29177873)
14. Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIBYIVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol. 1999;17:1339-1348. (Pubitemid 29220838)
15. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161. (Pubitemid 29177874)
16. Gaffney DK, Winter K, Dicker AP, et al. A phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys. 2007;67:104-109. (Pubitemid 44959486)
17. Gaffney DK, Winter K, Dicker AP, et al. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with Celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 2007;69:111-117. (Pubitemid 47247506)
18. Small W Jr, Winter K, Levenback C, et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007;68:1081-1087. (Pubitemid 47048563)
19. Kaplan E, Meier P. Nonparameteric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Kalbfleish J. The Statistical Analysis of Failure Time Data. In. New York: John Wiley & Sons; 1980:167-169.
21. Cox D. Regression models and life tables. J Royal Stat Soc. 1972;34:187-229.
22. Cox J, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
23. Small W Jr, Winter K, Levenback C, et al. Extended field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm 2 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007;69:S5.
24. Jampolis S, Andras EJ, Fletcher GH. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology. 1975;115:681-685.
25. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a Patterns-of-Care Study. Int J Radiat Oncol Biol Phys. 1993;25:391-398.
26. Viswanathan AN, Erickson BA. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2010;76:104-109.
27. Viswanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491-498. (Pubitemid 46694166)